John K. Scott Jr. - Apr 10, 2022 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Director, 10%+ Owner
Signature
/s/ Erika L. Eves for John K. Scott, Jr. by power of attorney
Stock symbol
NAVB
Transactions as of
Apr 10, 2022
Transactions value $
-$113,608
Form type
4
Date filed
5/3/2022, 07:12 PM
Previous filing
Mar 31, 2022
Next filing
Jun 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +2.5K +0.03% $0.00 8.09M Apr 30, 2022 Direct F1, F2
transaction NAVB Series G Redeemable Preferred Stock Purchase +3.26K 3.26K Apr 10, 2022 Direct F4
holding NAVB Common Stock 10.1K Apr 10, 2022 By spouse and children F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAVB Series E Redeemable Convertible Preferred Stock Sale -$115K -50K -100% $2.30* 0 Apr 10, 2022 Common Stock 2.17M $2.30 Direct F4
transaction NAVB Series F Redeemable Convertible Preferred Stock Purchase $1.39K +1.74K $0.80* 1.74K Apr 10, 2022 Common Stock 2.18M $0.80 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
F2 Issuance deferred at the request of the Reporting Person.
F3 Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed to have shared voting and/or dispositive power with respect to such shares.
F4 Series E Redeemable Convertible Preferred Stock, par value $.001 per share, was exchanged for Series F Redeemable Convertible Preferred Stock, par value $.001 per share, and Series G Redeemable Preferred Stock, par value $.001 per share.
F5 Series F Redeemable Convertible Preferred Stock, par value $.001 per share, is convertible at any time and has no expiration date.